These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26298227)

  • 41. A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents.
    Han Y; Xu B; Fu G; Wang X; Xu K; Jin C; Tao L; Li L; Hou Y; Su X; Fang Q; Chen L; Liu H; Wang B; Yuan Z; Gao C; Zhou S; Sun Z; Zhao Y; Guan C; Stone GW;
    JACC Cardiovasc Interv; 2018 Feb; 11(3):260-272. PubMed ID: 29413240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
    Lee WC; Fang HY; Fang CY
    Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
    [No Abstract]   [Full Text] [Related]  

  • 43. Step by step, the description of the "biodegradable" strategy for the treatment of coronary bifurcation lesions.
    Piraino D; Cimino G; Andolina G
    Int J Cardiol; 2016 Nov; 223():37-39. PubMed ID: 27529587
    [No Abstract]   [Full Text] [Related]  

  • 44. Angiographically minimal but functionally significant coronary lesion confirmed by optical coherence tomography.
    Yoon HJ; Cho YK; Nam CW; Kim KB; Hur SH
    Korean J Intern Med; 2016 Jul; 31(4):807-8. PubMed ID: 27320616
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 46. Bioresorbable Vascular Scaffold for the Treatment of Coronary Bifurcation Lesions: Immediate Results and 1-year Follow-up.
    Suárez de Lezo J; Martín P; Pan M; Ojeda S; Nóvoa J; Segura J; Mazuelos F; Romero M; Medina A; Suárez de Lezo J
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):554-62. PubMed ID: 26949014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The FIREHAWK stent: will it achieve its potential?
    Garg S
    EuroIntervention; 2013 May; 9(1):15-9. PubMed ID: 23685309
    [No Abstract]   [Full Text] [Related]  

  • 48. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
    Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study).
    Iannaccone M; Barbero U; De Benedictis M; Imori Y; Quadri G; Trabattoni D; Ryan N; Venuti G; Montabone A; Wojakowski W; Rognoni A; Helft G; Parma R; De Luca L; Autelli M; Boccuzzi G; Mattesini A; Templin C; Cerrato E; Wańha W; Smolka G; Huczek Z; Tomassini F; Cortese B; Capodanno D; Chieffo A; Nuñez-Gil I; Gili S; Bassignana A; di Mario C; Doronzo B; Omedè P; D'Amico M; Tedeschi D; Varbella F; Luscher T; Sheiban I; Escaned J; Rinaldi M; D'Ascenzo F
    BMC Cardiovasc Disord; 2020 May; 20(1):225. PubMed ID: 32414330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population.
    Wiebe J; Liebetrau C; Dörr O; Wilkens E; Bauer T; Elsässer A; Achenbach S; Möllmann H; Hamm CW; Nef HM
    Cardiovasc Revasc Med; 2015 Dec; 16(8):455-60. PubMed ID: 26428450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified T-technique with bioresorbable scaffolds ensures complete carina coverage: an optical coherence tomography study.
    van Mieghem N; Wilschut JJ; Ligthart J; Witberg K; van Geuns RJ; Regar E
    JACC Cardiovasc Interv; 2014 Aug; 7(8):e109-10. PubMed ID: 25086845
    [No Abstract]   [Full Text] [Related]  

  • 55. Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Grundeken MJ; Nakatani S; Asano T; Sotomi Y; Foin N; Ng J; Okamura T; Wykrzykowska JJ; de Winter RJ; van Geuns RJ; Koolen J; Christiansen EH; Whitbourn R; McClean D; Smits P; Windecker S; Ormiston JA; Serruys PW
    Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28893770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
    Naganuma T; Colombo A; Lesiak M; Capodanno D; Gori T; Nef H; Caramanno G; Naber C; Di Mario C; Ruparelia N; Capranzano P; Wiebe J; Araszkiewicz A; Geraci S; Kawamoto H; Pyxaras S; Mattesini A; Münzel T; Tamburino C; Latib A
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):47-56. PubMed ID: 27414021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paclitaxel crystals on the surface of a bioresorbable vascular scaffold visualized by optical coherence tomography after drug-eluting balloon angioplasty.
    López-Benito M; Pérez de Prado A; Cuellas C; Estévez R; Fernández-Vázquez F
    Eur Heart J Cardiovasc Imaging; 2017 Jun; 18(6):638. PubMed ID: 28329070
    [No Abstract]   [Full Text] [Related]  

  • 58. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 59. Excimer laser facilitated coronary angioplasty of a heavy calcified lesion treated with bioresorbable scaffolds.
    Mangieri A; Jabbour RJ; Tanaka A; Aurelio A; Colombo A; Latib A
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e149-e150. PubMed ID: 28472818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Collapse of a Bioresorbable Novolimus-Eluting Coronary Scaffold.
    Braun D; Baquet M; Massberg S; Mehilli J; Hausleiter J
    JACC Cardiovasc Interv; 2016 Jan; 9(1):e13-e14. PubMed ID: 26685077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.